Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma

Journal of Clinical Oncology

Volumn 20, Issue 15, 2002, Pages 3225-3235

  Spunt, Sheri L ^a   Hill, D Ashley ^a   Motosue, Alison M ^a   Billups, Catherine A ^a   Cain, Alvida M ^a   Rao, Bhaskar N ^a   Pratt, Charles B ^a   Merchant, Thomas E ^a   Pappo, Alberto S ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MALE; METASTASIS; NEWBORN; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; TREATMENT FAILURE; TUMOR VOLUME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SARCOMA; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036682012     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.06.066     Document Type: Article

References (48)

1. Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: A Pediatric Oncology Group study
2. Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: The St Jude Children's Research Hospital experience
3. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data
4. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial
5. Adjuvant chemotherapy for adult soft tissue sarcoma: Is there a standard of care?
6. Childhood soft tissue sarcoma: A 20-year experience
7. Prognostic factors for children and adolescents with surgically resected non-rhabdomyosarcoma soft tissue sarcoma: An analysis of 121 patients treated at St Jude Children's Research Hospital
8. The Intergroup Rhabdomyosarcoma Study: A preliminary report
9. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities
10. Prognostic factors in adult patients with locally controlled soft tissue sarcoma: A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group
11. Therapy for childhood soft-tissue sarcomas other than rhabdomyosarcoma: A review of 62 cases treated at a single institution
12. Pediatric nonrhabdomyosarcomas of the extremities: Influence of size, invasiveness, and grade on outcome
13. Nonrhabdomyosarcoma in children: Prognostic factors influencing survival
14. Nonrhabdomyosarcomatous soft tissue sarcomas of childhood: Formulation of a simplified system for grading
15. Soft tissue sarcoma
16. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples
17. A class of K-sample tests for comparing the cumulative incidence of a competing risk
18. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma
19. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: An analysis of 2,185 patients treated with anthracycline-containing first-line regimens - A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
20. Nonrhabdomyosarcoma soft tissue sarcomas in children: Is age at diagnosis an important variable?
21. Hemangiopericytoma in children and infants
22. Fibrosarcoma in infants and children: A review of 110 cases
23. Identification of a favorable subset of patients (pts) with metastatic (MET) rhabdomyosarcoma (RMS): A report from the Intergroup Rhabdomyosarcoma Study Group (IRSG)
24. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: Analysis of 359 patients at the Istituto Ortopedico Rizzoli
25. Accessing genetic information with high-density DNA arrays
26. Gene discovery using the serial analysis of gene expression technique: Implications for cancer research
27. Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group study
28. Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: Long-term results from a single institution
29. Impact of neoadjuvant therapy on local control of soft tissue sarcomas
30. Intensive induction chemotherapy in adult patients with advanced soft tissue sarcoma (ASTS): Clinical and histological response, surgical impact and follow-up after resection
31. A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma
32. Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas
33. Prognostic factors in adult soft-tissue sarcomas of the head and neck
34. Retroperitoneal soft-tissue sarcoma: Analysis of 500 patients treated and followed at a single institution
35. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: Implications for management
36. Low-grade soft tissue sarcomas of the extremities: Analysis of risk factors for metastasis
37. Treatment-induced pathologic necrosis: A predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas
38. Concomitant chemoradiotherapy treatment in locally advanced and/or metastatic soft tissue sarcomas (STS): Updated results of a twelve-year experience
39. Preoperative neoadjuvant chemotherapy and radiation for high grade extremity sarcomas: UCLA experience
40. Radiation Therapy Oncology Group (RTOG) 95-14: A phase II study of neoadjuvant chemotherapy (CT) and radiation therapy (RT) in high risk (HR), high grade, soft tissue sarcomas (STS) of the extremities and body wall - A preliminary report
41. Preoperative radiotherapy for extremity soft tissue sarcoma (STS): Site-specific wound complication rates and the impact of reconstructive surgery
42. Soft tissue sarcomas: Preoperative versus postoperative radiotherapy
43. Preoperative chemotherapy for soft tissue sarcomas of the extremities: The experience at the University of California, Los Angeles
44. Preoperative radiotherapy for initially inoperable extremity soft tissue sarcomas
45. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas
46. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas